Mostrar el registro sencillo del ítem
dc.contributor.author | Griffing, Sean M. | |
dc.contributor.author | Gamboa Vilela, Dionicia Baziliza | |
dc.contributor.author | Udhayakumar, Venkatachalam | |
dc.date.accessioned | 2022-01-04T20:31:45Z | |
dc.date.available | 2022-01-04T20:31:45Z | |
dc.date.issued | 2013 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12866/10599 | |
dc.description.abstract | Malaria has been part of Peruvian life since at least the 1500s. While Peru gave the world quinine, one of the first treatments for malaria, its history is pockmarked with endemic malaria and occasional epidemics. In this review, major increases in Peruvian malaria incidence over the past hundred years are described, as well as the human factors that have facilitated these events, and concerted private and governmental efforts to control malaria. Political support for malaria control has varied and unexpected events like vector and parasite resistance have adversely impacted morbidity and mortality. Though the ready availability of novel insecticides like DDT and efficacious medications reduced malaria to very low levels for a decade after the post eradication era, malaria reemerged as an important modern day challenge to Peruvian public health. Its reemergence sparked collaboration between domestic and international partners towards the elimination of malaria in Peru. | en_US |
dc.language.iso | eng | |
dc.publisher | BioMed Central | |
dc.relation.ispartofseries | Malaria Journal | |
dc.rights | info:eu-repo/semantics/restrictedAccess | |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es | |
dc.subject | Latin America | en_US |
dc.subject | unclassified drug | en_US |
dc.subject | Humans | en_US |
dc.subject | Peru | en_US |
dc.subject | public health | en_US |
dc.subject | insecticide | en_US |
dc.subject | parasite vector | en_US |
dc.subject | pyrethroid | en_US |
dc.subject | Drug resistance | en_US |
dc.subject | infection control | en_US |
dc.subject | incidence | en_US |
dc.subject | malaria control | en_US |
dc.subject | Plasmodium vivax | en_US |
dc.subject | Plasmodium vivax malaria | en_US |
dc.subject | epidemic | en_US |
dc.subject | morbidity | en_US |
dc.subject | methodology | en_US |
dc.subject | health care policy | en_US |
dc.subject | malaria falciparum | en_US |
dc.subject | Plasmodium falciparum | en_US |
dc.subject | Antimalarials | en_US |
dc.subject | chloroquine | en_US |
dc.subject | Malaria | en_US |
dc.subject | primaquine | en_US |
dc.subject | malaria | en_US |
dc.subject | history | en_US |
dc.subject | History, 20th Century | en_US |
dc.subject | antimalarial agent | en_US |
dc.subject | clindamycin | en_US |
dc.subject | population dynamics | en_US |
dc.subject | tetracycline | en_US |
dc.subject | Communicable Disease Control | en_US |
dc.subject | Health Policy | en_US |
dc.subject | artemisinin | en_US |
dc.subject | artesunate | en_US |
dc.subject | chlorphenotane | en_US |
dc.subject | Disease | en_US |
dc.subject | domestic partnership | en_US |
dc.subject | drug therapy | en_US |
dc.subject | Drug Therapy | en_US |
dc.subject | eradication therapy | en_US |
dc.subject | Falciparum | en_US |
dc.subject | Habitat change | en_US |
dc.subject | Malaria control | en_US |
dc.subject | Malaria eradication | en_US |
dc.subject | mefloquine | en_US |
dc.subject | mepacrine | en_US |
dc.subject | Pesticide resistance | en_US |
dc.subject | Plasmodium | en_US |
dc.subject | plasmoquine | en_US |
dc.subject | political system | en_US |
dc.subject | Public health | en_US |
dc.subject | quinine | en_US |
dc.subject | Quinine | en_US |
dc.subject | Vivax | en_US |
dc.title | The history of 20th century malaria control in Peru | en_US |
dc.type | info:eu-repo/semantics/article | |
dc.identifier.doi | https://doi.org/10.1186/1475-2875-12-303 | |
dc.subject.ocde | https://purl.org/pe-repo/ocde/ford#3.03.08 | |
dc.relation.issn | 1475-2875 |
Ficheros | Tamaño | Formato | Ver |
---|---|---|---|
No hay ficheros asociados a este ítem. |